SEC Form 4/A · accession 0001209191-18-044965
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Charles R Eyler
Officer — SEE REMARKS
Period of report
Jan 22, 2018
Accepted (ET)
Aug 2, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Jan 22, 2018 | S | 669 | $92.85 | D | 28,027 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2017 to satisfy tax obligations in connection with the vesting of restricted stock units.
- F2This amended Form 4 is filed solely for the purpose of correcting an administrative error in column 4 reporting securities as acquired, instead of disposed of, as reported on the Form 4 filed January 24, 2018.
Remarks
Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer